Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Temporal Trends in Antimicrobial Resistance and Virulence-Associated Traits within the Escherichia coli Sequence Type 131 Clonal Group and Its H30 and H30-Rx Subclones, 1968 to 2012

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. In-vivo gentamicin susceptibility test for prevention of bacterial biofilms in bone tissue and on implants

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the In Vivo Susceptibility in Invertebrate and Murine Models

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. APX001A In Vitro Activity against Contemporary Blood Isolates and Candida auris Determined by the EUCAST Reference Method

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Treatment of candidemia in a nationwide setting: increased survival with primary echinocandin treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Sequence Type 410 Is Causing New International High-Risk Clones

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Update from a twelve-year nationwide fungaemia surveillance: increasing intrinsic and acquired resistance causes concern

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Incidence of HACEK bacteraemia in Denmark: A 6-year population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

To identify possible explanations for the recent global emergence of Escherichia coli sequence type (ST) 131 (ST131), we analyzed temporal trends within ST131 O25 for antimicrobial resistance, virulence genes, biofilm formation, and the H30 and H30-Rx subclones. For this, we surveyed the WHO E. coli and Klebsiella Centre's E. coli collection (1957 to 2011) for ST131 isolates, characterized them extensively, and assessed them for temporal trends. Overall, antimicrobial resistance increased temporally in prevalence and extent, due mainly to the recent appearance of the H30 (1997) and H30-Rx (2005) ST131 subclones. In contrast, neither the total virulence gene content nor the prevalence of biofilm production increased temporally, although non-H30 isolates increasingly qualified as extraintestinal pathogenic E. coli (ExPEC). Whereas virotype D occurred from 1968 forward, virotypes A and C occurred only after 2000 and 2002, respectively, in association with the H30 and H30-Rx subclones, which were characterized by multidrug resistance (including extended-spectrum-beta-lactamase [ESBL] production: H30-Rx) and absence of biofilm production. Capsular antigen K100 occurred exclusively among H30-Rx isolates (55% prevalence). Pulsotypes corresponded broadly with subclones and virotypes. Thus, ST131 should be regarded not as a unitary entity but as a group of distinctive subclones, with its increasing antimicrobial resistance having a strong clonal basis, i.e., the emergence of the H30 and H30-Rx ST131 subclones, rather than representing acquisition of resistance by diverse ST131 strains. Distinctive characteristics of the H30-Rx subclone-including specific virulence genes (iutA, afa and dra, kpsII), the K100 capsule, multidrug resistance, and ESBL production-possibly contributed to epidemiologic success, and some (e.g., K100) might serve as vaccine targets.

Original languageEnglish
JournalAntimicrobial Agents and Chemotherapy
Volume58
Issue number11
Pages (from-to)6886-95
Number of pages10
ISSN0066-4804
DOIs
Publication statusPublished - Nov 2014

ID: 44705543